| Literature DB >> 26134197 |
Kenjiro Furuta1, Satoshi Ikeo, Takuya Takaiwa, Satoshi Ikeda, Akihiro Nishiyama, Toshihide Yokoyama, Akihiro Ito, Fumiaki Tokioka, Maki Tanaka, Hiroshige Yoshioka, Hiromasa Tachibana, Machiko Arita, Toru Hashimoto, Tadashi Ishida.
Abstract
Diaphenylsulfone (DDS: Dapsone) is used for Pneumocystis pneumonia (PCP) prophylaxis, and methemoglobinemia has rarely been reported as a side effect of DDS. We herein report two cases of DDS-related methemoglobinemia in an 81-year-old man with organizing pneumonia and an 84-year-old woman with eosinophilic pneumonia under treatment with prednisolone. Both patients initially received trimethoprim/sulfamethoxazole for PCP prophylaxis and were switched to DDS due to side effects and subsequently exhibited a clinically unexplainable decrease in SpO2. Methemoglobinemia was diagnosed based on the findings of arterial blood gas analyses. In both cases, the methemoglobinemia improved after discontinuing DDS.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26134197 DOI: 10.2169/internalmedicine.54.3496
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271